World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
14246
World Ranking
3221
National Ranking
278

Marco Londei publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marco Londei sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 177 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marco Londei D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marco Londei sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marco Londei is affiliated with University College London in the United Kingdom. Their research focuses largely on immunology and medicine, with particular attention to subfields including immunology, immunology and allergy, surgery, physiology, and genetics.

Their recent scholarly work encompasses several publications covering topics such as IL-33, ST2, and ILC pathways, food allergy and anaphylaxis research, eosinophilic esophagitis, asthma and respiratory diseases, and inflammatory bowel disease.

  • Optimal human pathogenic TH2 cell effector function requires local epithelial cytokine signaling, 2021, Journal of Allergy and Clinical Immunology
  • A randomized study assessing safety and efficacy of etokimab monotherapy in peanut allergic participants., 2020, World Allergy Organization Journal
  • Development of peanut allergy is associated with coding SNPs in the C-terminus of the IL-33 receptor that impact signaling and TH2 effector function, 2020, Journal of Allergy and Clinical Immunology
  • Rhinovirus & IL33 driven HBEC gene signatures are disease & IL1RL1 polymorphism dependent, 2020, Genes and Environment
  • 1014: DEVELOPMENT OF ALLOGENEIC ENGINEERED TYPE I REGULATORY T CELLS (TRX103) TO MODULATE INFLAMMATION AND PATHOGENIC T CELLS IN REFRACTORY CROHN'S DISEASE., 2025, Gastroenterology

Marco Londei has collaborated multiple times with a core group of frequent co-authors including Justine Calise, Nahir Garabatos, Mary Farrington, David Robinson, and David Jeong. These collaborations reflect ongoing partnerships in their fields of study and research interests.

Their research is published primarily in journals focused on allergy, immunology, and related medical sciences. Notable publication venues include:

  • Journal of Allergy and Clinical Immunology
  • World Allergy Organization Journal
  • Genes and Environment
  • Gastroenterology

Their research areas highlight complex immune signaling pathways and clinical conditions related to allergic responses and inflammatory diseases. Key topics they explore include:

  • IL-33, ST2, and ILC Pathways
  • Food Allergy and Anaphylaxis Research
  • Eosinophilic Esophagitis
  • Asthma and respiratory diseases
  • Inflammatory Bowel Disease

Best Publications

  • Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

    Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke

  • Prevention of Arthritis by Interleukin 10–producing B Cells

    Claudia Mauri;David Gray;Naseem Mushtaq;Marco Londei

  • Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

    Luigi Maiuri;Carolina Ciacci;Ida Ricciardelli;Loredana Vacca

  • DO CD4-POSITIVE CYTOTOXIC T CELLS DAMAGE ISLET β CELLS IN TYPE 1 DIABETES?

    P. De Berardinis;M. Londei;R. F. L. James;S. P. Lake

  • Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells

    Marco Londei;Jonathan R. Lamb;Gian Franco Bottazzo;Marc Feldmann

  • Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells.

    M Londei;GF Bottazzo;M Feldmann

  • Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

    A. P. Cope;M. Londei;N. R. Chu;S. B. A. Cohen

  • Interleukin 15 mediates epithelial changes in celiac disease

    Luigi Maiuri;Carolina Ciacci;Salvatore Auricchio;Virginia Brown

  • Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

    Marco Londei;Corinne M. Savill;Adrienne Verhoef;Fionula Brennan

  • CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians : implications for T cell memory

    Andrea Cossarizza;Claudio Ortolani;Roberto Paganelli;Daniela Barbieri

  • Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis.

    Yi-Ling Chen;Danuta Gutowska-Owsiak;Danuta Gutowska-Owsiak;Clare S. Hardman;Melanie Westmoreland

  • Celiac disease: In vitro and in vivo safety and palatability of wheat-free sorghum food products

    Carolina Ciacci;Luigi Maiuri;Luigi Maiuri;Nicola Caporaso;Cristina Bucci

  • CD4+ T-cell damage to islet beta cells.

    P. De Berardinis;M. Londei;R.F.L. James;S.P. Lake

  • Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease

    Antonio Picarelli;Luigi Maiuri;Antonella Frate;Marco Greco

  • Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.

    B Grubeck-Loebenstein;G Buchan;D Chantry;H Kassal

  • Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.

    B Grubeck-Loebenstein;G Buchan;R Sadeghi;M Kissonerghis

  • Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.

    Anne-Sophie Morel;Sonia Quaratino;Daniel Cesar Douek;Marco Londei

  • Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.

    Colin M. Dayan;Marco Londei;Anne E. Corcoran;Beatrix Grubeck-Loebenstein

  • Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.

    Sharon Chinthrajah;Shu Cao;Cherie Liu;Shu-Chen Lyu

  • Unexpected role of surface transglutaminase type II in celiac disease

    Luigi Maiuri;Carolina Ciacci;Ida Ricciardelli;Loredana Vacca

  • Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process.

    Claudia Mauri;Lennart T. Mars;Marco Londei

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Luigi Maiuri
Luigi Maiuri European Institute
Salvatore Auricchio
Salvatore Auricchio University of Naples Federico II
Martin R. Turner
Martin R. Turner University of Oxford
Fionula M. Brennan
Fionula M. Brennan University of Oxford
Basil Rapoport
Basil Rapoport University of California, San Francisco
Peter D. Katsikis
Peter D. Katsikis Erasmus University Rotterdam
Andrea Cossarizza
Andrea Cossarizza University of Modena and Reggio Emilia
Claudia Mauri
Claudia Mauri University College London
Ravinder N. Maini
Ravinder N. Maini Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing advanced nursing degrees online can open up diverse career paths. Psychiatric Nurse Practitioner roles, for example, are in high demand, and many students seek the best online pmhnp programs to ensure strong clinical placement rates and practical experience.

Cost is a major consideration when selecting a program. Prospective students often explore the cheapest psych np programs online to balance affordability with quality education, making advanced nursing degrees more accessible.

Career advancement is closely tied to earning potential. Understanding the dnp salary across different regions helps students plan their professional future in clinical or research settings related to immunology.

Nurses looking to specialize can also consider certification pathways. Transitioning from a Family Nurse Practitioner (FNP) to an acute care role is a valuable option, supported by the guidance available on acute care certification for fnp, enhancing both clinical skills and career prospects.

Best Scientists Citing Marco Londei

Trending Scientists

Recently Published Articles